Sim4Flow Secures Funding to Accelerate Aneurysm Risk Prediction
Sim4Flow, a leading innovator in AI-driven aneurysm management, is thrilled to announce that recently secured €120k funding from the competitive Pre-Seed (0823) call of Research and Innovation Foundation to accelerate the development and deployment of its groundbreaking solution, IRIS. This funding will enable Sim4Flow to expand its team, enhance its technology, and bring IRIS to more healthcare providers worldwide.
About IRIS:
IRIS is a cutting-edge AI-powered platform designed to revolutionize the management of intracranial aneurysms. By analyzing MRI and CT scans, IRIS provides clinicians with precise risk assessments and personalized treatment recommendations, empowering them to make informed decisions and improve patient outcomes.
Impact of the Funding:
The newly secured funding will be used to:
- Expand the Development Team: Sim4Flow will invest in hiring additional talented individuals to join our team, accelerating the development of IRIS and ensuring its continued innovation.
- Enhance Technology: The funding will support the ongoing development and refinement of IRIS, incorporating the latest advancements in AI and machine learning.
- Expand Market Reach: Sim4Flow will use the funds to increase awareness of IRIS and expand its market reach, bringing this valuable tool to more healthcare providers worldwide.
"We are thrilled to secure this funding, which will enable us to accelerate the development of IRIS and bring it to even more healthcare providers worldwide. Our vision is to transform the management of intracranial aneurysms, and this investment brings us one step closer to realizing that goal."
Nikolas Aristokleous - CEO/Founder Sim4Flow
Sim4Flow is excited about the future of aneurysm management and the potential of IRIS to transform patient care. With the support of this new funding, we are committed to accelerating the development and deployment of IRIS, making a significant impact on the lives of patients with intracranial aneurysms.